SEC 13F Intelligence

Nwam LLC / LLY

Nwam LLC’s Eli Lilly & Co Position

Does Nwam LLC own Eli Lilly & Co (LLY)? Yes14.5K shares worth $13M (+0.77% of its 13F portfolio) as of Q1 2026, up from 14.1K shares the prior filed quarter.

Position Value
$13M
Q1 2026
Shares
14.5K
% of Portfolio
+0.77%
Quarters Held
28
currently held

Position History LLY

Reported value by quarter
Q4 ’18: $385,000Q4 ’18Q1 ’19: $432,000Q2 ’19: $369,000Q3 ’19: $378,000Q4 ’19: $482,000Q4 ’19Q1 ’20: $508,000Q2 ’20: $625,000Q4 ’20: $611,000Q1 ’21: $623,000Q1 ’21Q2 ’21: $823,000Q3 ’21: $793,000Q4 ’21: $954,000Q1 ’22: $1MQ1 ’22Q2 ’22: $1MQ3 ’22: $1MQ4 ’22: $4MQ1 ’23: $4MQ1 ’23Q2 ’23: $6MQ3 ’23: $6MQ4 ’23: $8MQ1 ’24: $10MQ1 ’24Q3 ’24: $12MQ4 ’24: $11MQ1 ’25: $1MQ2 ’25: $1MQ2 ’25Q3 ’25: $1MQ4 ’25: $10MQ1 ’26: $13Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202614.5K$13M+0.77%
Q4 202514.1K$10M+0.61%
Q3 20251.8K$1M+0.10%
Q2 20251.7K$1M+0.11%
Q1 20251.7K$1M+0.12%
Q4 202413.7K$11M+0.65%
Q3 202413.2K$12M+0.71%
Q1 202413.3K$10M+0.83%
Q4 202313.1K$8M+0.62%
Q3 202311.6K$6M+0.63%
Q2 202313.6K$6M+0.52%
Q1 202311.3K$4M+0.39%
Q4 202211.5K$4M+0.37%
Q3 20224.1K$1M+0.13%
Q2 20223.9K$1M+0.12%
Q1 20223.9K$1M+0.08%
Q4 20213.5K$954,000+0.08%
Q3 20213.4K$793,000+0.07%
Q2 20213.6K$823,000+0.08%
Q1 20213.3K$623,000+0.06%
Q4 20203.6K$611,000+0.07%
Q2 20203.8K$625,000+0.09%
Q1 20203.7K$508,000+0.01%
Q4 20193.7K$482,000+0.08%
Q3 20193.4K$378,000+0.07%
Q2 20193.3K$369,000+0.07%
Q1 20193.3K$432,000+0.09%
Q4 20183.3K$385,000+0.10%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Nwam LLC’s full portfolio or all institutional holders of LLY.